HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Md Abdul Hye Khan Selected Research

Md Abdul Hye Khan Research Topics

Disease

9Hypertension (High Blood Pressure)
01/2021 - 05/2012
9Fibrosis (Cirrhosis)
10/2020 - 11/2013
6Inflammation (Inflammations)
03/2021 - 12/2012
3Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2018 - 12/2012
2Ureteral Obstruction
10/2020 - 05/2016
2Myocardial Infarction
01/2019 - 11/2018
2Proteinuria
01/2019 - 01/2016
2Heart Failure
01/2019 - 10/2018
2Insulin Resistance
10/2018 - 06/2011
2Albuminuria
12/2012 - 05/2012
1Chronic Renal Insufficiency
03/2021
1Cardiomegaly (Heart Hypertrophy)
01/2021
1Alcoholic Fatty Liver
01/2019
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2019
1Lupus Nephritis
01/2019
1Hypoxia (Hypoxemia)
11/2018
1Infarction (Infarctions)
11/2018
1Reperfusion Injury
11/2018
1Diabetic Nephropathies (Diabetic Nephropathy)
10/2018
1Liver Diseases (Liver Disease)
10/2018
1Type 2 Diabetes Mellitus (MODY)
10/2018
1Diabetes Complications
10/2018
1Vascular System Injuries
08/2014
1Thrombotic Microangiopathies
05/2012
1Hyperinsulinism (Hyperinsulinemia)
06/2011
1Ischemia
01/2010
1Body Weight (Weight, Body)
11/2007
1Renal Insufficiency (Renal Failure)
11/2007

Drug/Important Bio-Agent (IBA)

9AcidsIBA
03/2021 - 11/2013
3CollagenIBA
10/2020 - 05/2016
3Epoxide HydrolasesIBA
10/2020 - 10/2018
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2020 - 12/2012
3LipidsIBA
01/2019 - 08/2014
3EET-BIBA
01/2019 - 11/2013
314,15-epoxy-5,8,11-eicosatrienoic acidIBA
11/2018 - 01/2016
3SodiumIBA
03/2014 - 11/2007
2Cisplatin (Platino)FDA LinkGeneric
03/2021 - 11/2007
2Messenger RNA (mRNA)IBA
10/2020 - 01/2019
2CreatinineIBA
01/2019 - 11/2007
2EnzymesIBA
11/2018 - 01/2017
2Glucose (Dextrose)FDA LinkGeneric
10/2018 - 08/2014
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2018 - 05/2012
2Captopril (Capoten)FDA LinkGeneric
04/2016 - 05/2012
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2016 - 08/2014
2Malondialdehyde (Propanedial)IBA
01/2016 - 08/2014
2Antihypertensive Agents (Antihypertensives)IBA
10/2014 - 08/2014
2azilsartan medoxomilIBA
08/2014 - 08/2014
2FructoseIBA
03/2014 - 06/2011
1Therapeutic UsesIBA
03/2021
1CalciumIBA
01/2021
1Choline (Choline Chloride)IBA
01/2019
1Methionine (L-Methionine)FDA Link
01/2019
1Streptozocin (Streptozotocin)FDA Link
01/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1CytokinesIBA
01/2019
1ChemokinesIBA
01/2019
1Heme Oxygenase-1IBA
01/2019
1Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
11/2018
1Blood Glucose (Blood Sugar)IBA
10/2018
1EnalaprilFDA LinkGeneric
10/2018
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2018
1salicylhydroxamic acid (SHAM)IBA
01/2017
119,20-epoxydocosapentaenoic acidIBA
05/2016
1Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
05/2016
1Hydroxyproline (4 Hydroxyproline)IBA
05/2016
1Proteins (Proteins, Gene)FDA Link
01/2016
1Cyclosporine (Ciclosporin)FDA LinkGeneric
01/2016
1Angiotensin IIIBA
10/2014
1Epithelial Sodium ChannelsIBA
10/2014
1ElectrolytesIBA
10/2014
1Drinking WaterIBA
10/2014
1Angiotensin II Type 1 Receptor BlockersIBA
08/2014
1Angiotensin Receptor AntagonistsIBA
08/2014
1Bicarbonates (Hydrogen Carbonate)IBA
03/2014
1Sodium-Hydrogen Exchanger 3IBA
03/2014
1AlbuminsIBA
11/2013
1SaltsIBA
11/2013
1nephrinIBA
11/2013
1Rosiglitazone (Avandia)FDA Link
12/2012
1Sorafenib (BAY 43-9006)FDA Link
05/2012
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2012
1Pentobarbital (Nembutal)FDA Link
01/2010
1PotassiumIBA
01/2010
1Adrenergic alpha-Agonists (Adrenergic alpha-Agonist)IBA
11/2007
1Adrenergic Agents (Adrenergic Drugs)IBA
11/2007

Therapy/Procedure

2Therapeutics
01/2019 - 05/2012